Literature DB >> 3121580

Inhibition of mitochondrial carbonic anhydrase and ureagenesis: a discrepancy examined.

S J Dodgson1.   

Abstract

The amount of urea synthesized in intact guinea pig hepatocytes in 60 min ([urea]t=60), was determined at 37 degrees C in Krebs-Henseleit buffer plus (in mM) 10 NH4Cl, 5 lactate, and 10 ornithine in 5% CO2-95% O2. The concentrations of sulfonamide carbonic anhydrase (CA) inhibitors required to reduce the rate of urea synthesis by 50% (I50) were (in mM): 0.07 ethoxzolamide, 0.5 methazolamide, 0.7 acetazolamide, and 5.0 p-aminomethylbenzenesulfonamide. At 37 degrees C acetazolamide and ethoxzolamide reduced citrulline synthesis by intact mitochondria in medium containing (in mM) 50 3-(N-morpholino)propanesulfonic acid, 35 KCl, 5 KH2PO4, 2 adenosine triphosphate, 10 ornithine, 10 NH4Cl, 1 [ethylene-bis(oxyethylenenitrile)]tetraacetic acid, 1 MgCl2, 20 pyruvate, and 25 KHCO3 (pH 7.4) in 5% CO2-95% O2; the inhibition by ethoxzolamide was not decreased greater than 50%; 25% inhibition was achieved by 0.65 microM ethoxzolamide. Inhibition constant (Ki) values for CA activity of disrupted mitochondria at 37 degrees C were 0.03 microM ethoxzolamide and 0.16 microM acetazolamide, and for disrupted hepatocytes were 150 microM ethoxzolamide and 50 microM acetazolamide. p-Aminomethylaminosulfonamide-affinity column purification yields one band of 29,000 mol wt for CA V purified from disrupted mitochondria; homogenized whole-liver supernatant yields an additional band of 20,000 mol wt (at greater than 100 times the concentration of CA V), which has some glutathione S-transferase activity. It is concluded that this 20,000-mol wt protein modifies the potency of ethoxzolamide in the liver cytosol.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3121580     DOI: 10.1152/jappl.1987.63.5.2134

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  7 in total

1.  From Homology Modeling to the Hit Identification and Drug Repurposing: A Structure-Based Approach in the Discovery of Novel Potential Anti-Obesity Compounds.

Authors:  Giosuè Costa; Anna Artese; Francesco Ortuso; Stefano Alcaro
Journal:  Methods Mol Biol       Date:  2021

2.  Immunohistochemical demonstration of human carbonic anhydrase isoenzyme II in brain tumours.

Authors:  A K Parkkila; R Herva; S Parkkila; H Rajaniemi
Journal:  Histochem J       Date:  1995-12

3.  Mitochondrial carbonic anhydrase CA VB: differences in tissue distribution and pattern of evolution from those of CA VA suggest distinct physiological roles.

Authors:  G N Shah; D Hewett-Emmett; J H Grubb; M C Migas; R E Fleming; A Waheed; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

4.  Targeted mutagenesis of mitochondrial carbonic anhydrases VA and VB implicates both enzymes in ammonia detoxification and glucose metabolism.

Authors:  Gul N Shah; Timothy S Rubbelke; Joshua Hendin; Hien Nguyen; Abdul Waheed; James D Shoemaker; William S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-15       Impact factor: 11.205

5.  Mitochondrial carbonic anhydrase (isozyme V) in mouse and rat: cDNA cloning, expression, subcellular localization, processing, and tissue distribution.

Authors:  Y Nagao; M Srinivasan; J S Platero; M Svendrowski; A Waheed; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

Review 6.  Carbonic Anhydrases: Role in pH Control and Cancer.

Authors:  Mam Y Mboge; Brian P Mahon; Robert McKenna; Susan C Frost
Journal:  Metabolites       Date:  2018-02-28

7.  Acetazolamide modulates intracranial pressure directly by its action on the cerebrospinal fluid secretion apparatus.

Authors:  Dagne Barbuskaite; Eva K Oernbo; Jonathan H Wardman; Trine L Toft-Bertelsen; Eller Conti; Søren N Andreassen; Niklas J Gerkau; Christine R Rose; Nanna MacAulay
Journal:  Fluids Barriers CNS       Date:  2022-06-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.